TL;DR: Ritivel is a Y Combinator Winter 2026 startup AI-native platform for Life-Sciences Documentation , currently active with a team of 3.
AI-native platform for Life-Sciences Documentation
Last verified:
Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster. Every month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and more importantly, delays treatment for thousands of patients who need it. Yet regulatory teams are stuck in a painful, months-long process: synthesizing thousands of pages of clinical data, hunting through SharePoint folders for the right documents, chasing colleagues for missing inputs, and manually drafting submissions. Ritivel deploys AI agents that transform how regulatory teams work. Our agents generate comprehensive first drafts directly in Microsoft Word, following FD…
Built by LemStudio
Yes. Ritivel was funded by Y Combinator in the Winter 2026 batch. AI-native platform for Life-Sciences Documentation
Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster. Every month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and…
Ritivel was part of Y Combinator's Winter 2026 batch.
Ritivel has a team of 3 people according to Y Combinator's directory.
Ritivel is currently listed as Active with a team of 3 in Y Combinator's directory.
Loading interactive view…